Reply to comment

I would like Robert Billings, vice president of policy for the Generic Pharmaceutical Association to show me, the consumer, just how the "pay to delay" benefits anyone except the drug companies. 'Big' and 'Little' Pharma has played these games for years and its high time they are being called on it. They just can't seem to quit bleeding the consumer with outrageous prices when their patents run out. And they try to get the generic manufacturers in bed with them. Billings must think we are all stupid! Sock it to them, FTC....

Reply

The content of this field is kept private and will not be shown publicly.